Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma. | Front Immunol | 2022 | 36532035 | PubTator, text mining | PubMed |
| The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer. | Front Oncol | 2022 | 36531072 | PubTator, text mining | PubMed |
| Oncolytic virus: A catalyst for the treatment of gastric cancer. | Front Oncol | 2022 | 36505792 | PubTator, text mining | PubMed |
| Detection of Kita-Kyushu Lung Cancer Antigen-1, a Cancer/Testis Antigen, in the Stomach Close to a Cancerous Condition. | J Cancer | 2022 | 36484013 | PubTator, text mining | PubMed |
| Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations. | Front Immunol | 2022 | 36483545 | PubTator, text mining | PubMed |
| Development of therapeutic vaccines for the treatment of diseases. | Mol Biomed | 2022 | 36477638 | PubTator, text mining | PubMed |
| Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges. | Aging Dis | 2022 | 36465180 | PubTator, text mining | PubMed |
| Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism. | Int J Mol Sci | 2022 | 36430456 | PubTator, text mining | PubMed |
| Nucleic acid vaccination strategies for ovarian cancer. | Front Bioeng Biotechnol | 2022 | 36420446 | PubTator, text mining | PubMed |
| Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy. | J Exp Clin Cancer Res | 2022 | 36397155 | PubTator, text mining | PubMed |
| Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy. | Front Immunol | 2022 | 36389724 | PubTator, text mining | PubMed |
| Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma. | Front Genet | 2022 | 36386793 | PubTator, text mining | PubMed |
| Autoantibodies - enemies, and/or potential allies? | Front Immunol | 2022 | 36341384 | PubTator, text mining | PubMed |
| Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors? | Front Immunol | 2022 | 36341370 | PubTator, text mining | PubMed |
| TCR mimic compounds for pHLA targeting with high potency modalities in oncology. | Front Oncol | 2022 | 36338746 | PubTator, text mining | PubMed |
| A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database. | Hum Vaccin Immunother | 2022 | 36328513 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future. | Front Pharmacol | 2022 | 36324681 | PubTator, text mining | PubMed |
| Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience. | Pharmaceutics | 2022 | 36297598 | PubTator, text mining | PubMed |
| Alterations in Gene Pair Correlations as Potential Diagnostic Markers for Colon Cancer. | Int J Mol Sci | 2022 | 36293321 | PubTator, text mining | PubMed |
| Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules. | Thorac Cancer | 2022 | 36284506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=10